Skip to content

Age Dependency of Biological Reaction on Wear Particles

Age Dependency of Biological Reaction on Wear Particles

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03164733
Enrollment
80
Registered
2017-05-24
Start date
2017-08-31
Completion date
2020-08-31
Last updated
2017-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty, Wear

Brief summary

Wear is the main reason for revision operations after joint arthroplasty. While the survival of modern implants is often longer than the expected life span in old patients, young patients (\<60 years) have to expect at least one wear induced revision operation. The reason is the throughout all registries consistantly significantly reduced implant survival rates in young patients. In the swedish arthrplasty registry the 15 year survival for patients older than 75 years is 95 % and for those younger than 50 years is 75 %. This corresponds to a 5fold increased revision rate (5 % vs. 25 %) 15 years after implantation. This significant difference cannot be explained by the higher activity of younger patients alone. Patient specific factors, that modulate the biological reaction on wear particles, are therefore highly probable. These could explain the significant age dependency of implant survival. The main hypothesis of this study is therefore, that the biological reaction on wear particles depends on the patients age.

Interventions

standardized wear particles are co-incubated with isolated patient cells (monocytes)

Sponsors

University of Jena
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* having received a total hip arthroplasty 4 weeks before blood sample for this study

Exclusion criteria

* no informed consent

Design outcomes

Primary

MeasureTime frameDescription
biological reactionone hourTNF-alpha concentration one hour after incubation of patient cells with wear particles in-vitro

Contacts

Primary ContactGeorg Matziolis, MD PhD
g.matziolis@krankenhaus-eisenberg.de+49 36691 81011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026